Mazdutide 10 mg – Multi-Receptor Metabolic Research Peptide

Mazdutide (IBI362 / LY3305677, CAS 2259884-03-0): Molecular Mechanism and Metabolic Research Overview

Mazdutide is a synthetic dual peptide agonist studied for its interaction with glucagon-like peptide-1 receptors (GLP-1R) and glucagon receptors (GCGR). Originally developed as LY3305677 and later advanced by Innovent Biologics, it is structurally based on oxyntomodulin (OXM), an endogenous peptide associated with metabolic signaling pathways.

Mazdutide is engineered as a long-acting peptide analog designed to support sustained receptor interaction in experimental and clinical research settings. Its structure combines GLP-1R and GCGR agonism in a balanced signaling profile, making it relevant for studies involving energy regulation, endocrine signaling, and metabolic pathway coordination.

Molecular Design and Receptor Binding

Mazdutide is a linear peptide built on the mammalian oxyntomodulin backbone, which contains the glucagon sequence with an additional C-terminal extension.

Targeted amino acid modifications and lipidation strategies enhance resistance to enzymatic degradation, improve albumin binding, and prolong circulation time in experimental systems.

Both GLP-1R and GCGR belong to the class B G-protein-coupled receptor (GPCR) family. Ligand binding induces conformational changes in extracellular and transmembrane receptor domains, promoting activation of intracellular Gs signaling pathways.

Mazdutide stabilizes active receptor conformations across both receptor systems, enabling coordinated signaling activity.

Downstream Signaling: Cyclic Adenosine Monophosphate (cAMP) Pathways

The primary signaling mechanism for both receptors involves activation of adenylyl cyclase through Gs proteins, leading to elevated intracellular cyclic adenosine monophosphate (cAMP) levels.

Increased cAMP activates protein kinase A (PKA), which modulates multiple downstream cellular processes.

GLP-1R Pathways

GLP-1 receptor signaling is studied in relation to:

• pancreatic endocrine signaling
• gastrointestinal regulatory pathways
• hypothalamic nutrient-sensing systems

GCGR Pathways

Glucagon receptor signaling is associated with:

• hepatic metabolic regulation
• lipid metabolism pathways
• mitochondrial fatty acid oxidation
• energy expenditure signaling systems

Integrated Metabolic Signaling

Mazdutide is studied for its ability to engage both appetite-related and energy-regulation pathways simultaneously.

Research models examine how:

• GLP-1R signaling influences nutrient-related feedback systems
• GCGR activation affects lipid metabolism and mitochondrial activity
• coordinated receptor activation impacts metabolic pathway integration

These pathways are explored in relation to complex endocrine and metabolic signaling networks.

Importance of Balanced Dual Agonism

Native oxyntomodulin naturally interacts with both GLP-1R and GCGR but has limited stability and short duration of activity.

Mazdutide’s structural modifications enhance receptor interaction and signaling persistence while preserving balanced dual agonism across both receptor systems.

This balanced profile is studied for its influence on:

• metabolic flexibility
• mitochondrial energy signaling
• lipid metabolism pathways
• coordinated endocrine regulation

Comparative Overview of Multi-Receptor Metabolic Peptides

Summary

Mazdutide is a dual GLP-1R and GCGR agonist studied for its role in coordinated metabolic signaling and endocrine pathway regulation.

Its mechanisms are associated with:

• cAMP-mediated GPCR signaling
• GLP-1 and glucagon receptor activation
• mitochondrial and lipid metabolism pathways
• integrated energy regulation systems

As a research peptide and metabolic signaling compound, mazdutide is explored to better understand how balanced multi-receptor activation influences complex biological and endocrine networks.

All information presented is based on experimental and clinical research data and is intended for scientific and educational purposes only.